Novo Nordisk and Eli Lilly rival soars 26% after promising weight-loss drug results ...United Arab Emirates

CNBC - Economy
Novo Nordisk and Eli Lilly rival soars 26% after promising weight-loss drug results
Zealand Pharma's Phase 2 trial was an "uniquivocal win" for a drug that can treat both liver disease and obesity, analysts said.

Hence then, the article about novo nordisk and eli lilly rival soars 26 after promising weight loss drug results was published today ( ) and is available on CNBC ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Novo Nordisk and Eli Lilly rival soars 26% after promising weight-loss drug results )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in Economy


Latest News